HomeGH • NASDAQ
add
Guardant Health Inc
Previous close
$98.14
Day range
$88.88 - $95.24
Year range
$23.73 - $100.21
Market cap
11.98B USD
Avg Volume
2.70M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 265.20M | 38.50% |
Operating expense | 270.48M | 15.60% |
Net income | -92.72M | 13.95% |
Net profit margin | -34.96 | 37.88% |
Earnings per share | -0.39 | 13.33% |
EBITDA | -89.47M | 15.91% |
Effective tax rate | -0.15% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 470.51M | -49.24% |
Total assets | 1.28B | -17.02% |
Total liabilities | 1.63B | 2.03% |
Total equity | -354.47M | — |
Shares outstanding | 126.04M | — |
Price to book | -34.56 | — |
Return on assets | -18.95% | — |
Return on capital | -24.71% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -92.72M | 13.95% |
Cash from operations | -35.41M | 30.64% |
Cash from investing | -14.35M | 95.13% |
Cash from financing | 4.33M | 250.12% |
Net change in cash | -45.96M | 86.75% |
Free cash flow | -19.90M | -15.73% |
About
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
Founded
2012
Headquarters
Website
Employees
2,010
